NICE says to restrict antibiotics in COPD

NICE says to restrict antibiotics in COPD

July 13 2018 Draft guidance is calling for health professionals to consider the risk of...

NICE updates guideline on rheumatoid arthritis

NICE updates guideline on rheumatoid arthritis

July 13 2018 NICE has issued a new version of its guideline on the management of rheumatoid...

Community pharmacy option for antihypertensives referral sees little increase in GP workload

Community pharmacy option for antihypertensives referral sees little increase in GP workload

July 11 2018 Community pharmacy referrals for hypertensive patients under the New Medicines...

CMO concludes cannabis products should move out of Schedule 1 classification

CMO concludes cannabis products should move out of Schedule 1 classification

July 9 2018 The Chief Medical Officer has recommended rescheduling cannabis-based products as...

GP partnership review invites views on how to reinvigorate the model

GP partnership review invites views on how to reinvigorate the model

July 6 2018 The Department of Health and Social Care has set out the lines of inquiry for the...

  • NICE says to restrict antibiotics in COPD

    NICE says to restrict antibiotics in COPD

    Friday, 13 July 2018 13:05
  • NICE updates guideline on rheumatoid arthritis

    NICE updates guideline on rheumatoid arthritis

    Friday, 13 July 2018 12:58
  • Community pharmacy option for antihypertensives referral sees little increase in GP workload

    Community pharmacy option for antihypertensives referral sees little increase in GP workload

    Wednesday, 11 July 2018 13:17
  • CMO concludes cannabis products should move out of Schedule 1 classification

    CMO concludes cannabis products should move out of Schedule 1 classification

    Monday, 09 July 2018 09:26
  • GP partnership review invites views on how to reinvigorate the model

    GP partnership review invites views on how to reinvigorate the model

    Friday, 06 July 2018 15:17

A Resized Diabetes Image cbAugust 3 2017

Prescribing for diabetes medicines in England increased 80.1% over the past decade, when overall prescribing item numbers increased only 46.0%. In the past year, total diabetes prescription items grew at 4.7% compared to total prescription item growth of 2.0%

The figures come in a new report from NHS Digital, ‘Prescribing for Diabetes: England 2006/07 to 2016/17’. Some “52.0 million items were prescribed for diabetes in 2016-17, up from 49.7 million in 2015-16, and 28.9 million in 2006-07,” it said.

Based on available data, primary care prescribing for diabetes has increased 40.0% between 2009-10 and 2016-17, whereas recorded diabetes prevalence only increased 22%. Metformin prescribing rose 51.1%.

Professor Helen Stokes-Lampard, RCGP Chair, commented: “A rise in prescriptions can indicate both better identification of diabetes at an earlier stage and more comprehensive treatment according to latest guidelines, but it is clear from these figures that more people are living with both type 1 and 2 diabetes long term - and this poses major challenges for the NHS.”

It was important that all patients with diabetes to be given the most appropriate treatments for them, regardless of the cost, and GPs “need to really push the prevention agenda,” she said. Referring to the “positive strides” being made by the NHS Diabetes Prevention Programme, she said it was encouraging to see this is being rolled out further.

Links:
NHS Digital announcement         
NHS analysis        
RCGP comment                

Professional News

July 13 2018 Draft guidance is calling for health professionals to consider the risk of antimicrobial resistance when prescribing for chronic obstructive pulmonary disease (COPD).
July 11 2018 Community pharmacy referrals for hypertensive patients under the New Medicines Service has not increased GP workload appreciably. Analysis of 131,419 patient records in England has...